Information Library
Results for: Case Studies - Flexible outsourcing - Get to market faster
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Securing Compliance
January 27, 2011
Our customer trusted Quintiles to handle the entire project, and – equally important – to ensure timely delivery. -
Re-energizing a Brand
September 1, 2010
Learn how Quintiles revamped the consumer marketing plan for an oral health product, boosting brand awareness by 90% and expanding the overall market size. -
Syndicated Solutions
June 30, 2010
Astellas needed to rapidly ramp up its sales force by 50% to take advantage of a projected $1 billion opportunity. Quintiles provided a new risk. -
Global Flexibility
May 9, 2010
PharmaMar needed to mobilize an effective sales force covering a market that spanned several countries and 20 official languages. With Quintiles, on-time recruitment against aggressive timelines made it possible to top sales goals in the first year. -
Blockbuster Co-Promotion
May 9, 2010
A pharma company targeted seven countries for quickly promoting its new compound. In just four months, Quintiles recruited, trained and implemented highly effective field sales teams in all seven new countries. -
Agile Outsourcing
May 9, 2010
Read how Quintiles established a pan-European infrastructure, recruited senior management and was achieving KPIs across 12 countries in just eight months. -
Bridging Cultures
May 9, 2010
Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise. -
Collaborative Promotion
May 9, 2010
Learn what happened when Quintiles was chosen to fulfill and manage a syndicated project working closely with a woundcare company's sales team. -
Maneuvering a Drifting Project Back on Course
March 25, 2009
The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.
Page 1 of 1 (9 results)